WW International reported a decrease in revenue for Q1 2025 compared to the prior year, primarily due to headwinds in the Behavioral business. However, the Clinical business showed strong growth, and the company significantly improved its Adjusted EBITDAS and Net Loss.
Total revenues were $186.6 million, down 9.7% year-over-year.
Net loss improved significantly to $72.6 million compared to $347.9 million in the prior year period.
Adjusted EBITDAS increased substantially to $26.9 million from $7.2 million in the prior year period.
End of Period Subscribers decreased by 14.2%, but End of Period Clinical Subscribers increased by 55.2%.
The company is not providing full year fiscal 2025 guidance at this time. They are engaged in substantive discussions with lenders and noteholders regarding a plan of reorganization to significantly reduce debt, expected to reach resolution imminently.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance